Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5912644 | Multiple Sclerosis and Related Disorders | 2015 | 9 Pages |
Abstract
Rates of mortality and several comorbidities are higher in the MS versus non-MS cohort. Early recognition and management of comorbidities may reduce premature mortality and improve quality of life in patients with MS.
Keywords
DMTsCoDsInternational Classification of Diseases 9th RevisionInternational Classification of Diseases 10th revisionDODMRRICD-9ERRICD-10EMRUTINDICLDadministrative claimsClinical Modificationstandard deviationcardiovascular diseasedisease-modifying therapiesCNSICDCVDcentral nervous systemNational Death IndexInternational Classification of DiseaseCauses of deathconfidence intervalnot applicableelectronic medical recordMultiple sclerosisMortality ratesEvent rateMortality rate ratioComorbiditiesDepartment of Defense
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Genetics
Authors
Gorana Capkun, Frank Dahlke, Raquel Lahoz, Beth Nordstrom, Hugh H Tilson, Gary Cutter, Dorina Bischof, Alan Moore, Jason Simeone, Kathy Fraeman, Fabrice Bancken, Yvonne Geissbühler, Michael (CAPT), Stanley Cohan,